Legacy Research Institute

Portland, Oregon 97232

2 studies enrolling now · 14 studies all time

What they study most

Addiction, Alzheimer Disease, Cognition Disorders, Diabetes Mellitus, Gastroesophageal Reflux Disease (GERD), Giant Cell Glioblastoma, Glioblastoma, Glioblastoma With Oligodendroglial Component, Gliosarcoma, Idiopathic Pulmonary Fibrosis, Insomnia, Interstitial Lung Disease

Studies at this site

• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) — Recruiting now
• Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF — Running, not enrolling
• Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking — Starting soon
• Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States — Completed
• Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension — Completed
• A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Stopped early
• Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Completed
• A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma — Completed
• Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy — Completed
• Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials — Completed
• Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes — Completed
• Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese — Stopped early
• Artificial Pancreas Control System in an Outpatient Setting — Completed